Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer, for the month of August 2021. The filing, dated August 16, 2021, incorporates by reference a press release issued on the same date. The registrant is based in Jerusalem, Israel, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a vehicle to distribute a press release and does not contain a financial statement or quantitative financial data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The document consists solely of the cover page and incorporation of an exhibit (Press Release dated August 16, 2021), without detailing specific operational or financial changes in the text provided.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the attached press release (Exhibit 99.1), the content of which is not included in the provided text.
Key Facts for Investor Verification
- Verify the specific content of the press release dated August 16, 2021 (Exhibit 99.1), as this Form 6-K only incorporates it by reference.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that no financial data is presented directly in this filing document.